
Arpad Fabian-kovacs
Examiner (ID: 16444)
Most Active Art Unit | 3671 |
Art Unit(s) | 3616, 3671 |
Total Applications | 3046 |
Issued Applications | 2528 |
Pending Applications | 99 |
Abandoned Applications | 392 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6236893
[patent_doc_number] => 20100267803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Regulators Of Fat Metabolism As Anti-Cancer Targets'
[patent_app_type] => utility
[patent_app_number] => 12/613953
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20537
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613953 | Regulators Of Fat Metabolism As Anti-Cancer Targets | Nov 5, 2009 | Abandoned |
Array
(
[id] => 6236892
[patent_doc_number] => 20100267802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'DELIVERY METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/610330
[patent_app_country] => US
[patent_app_date] => 2009-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15728
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267802.pdf
[firstpage_image] =>[orig_patent_app_number] => 12610330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/610330 | DELIVERY METHOD | Oct 31, 2009 | Abandoned |
Array
(
[id] => 7808091
[patent_doc_number] => 20120059045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHODS OF USING OLIGOMERIC COMPOUNDS COMPRISING 2\'-SUBSTITUTED NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 13/125560
[patent_app_country] => US
[patent_app_date] => 2009-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23271
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059045.pdf
[firstpage_image] =>[orig_patent_app_number] => 13125560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125560 | METHODS OF USING OLIGOMERIC COMPOUNDS COMPRISING 2'-SUBSTITUTED NUCLEOSIDES | Oct 22, 2009 | Abandoned |
Array
(
[id] => 7744868
[patent_doc_number] => 20120022245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'FOLATE TARGETING OF NUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/124408
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 43106
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022245.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124408
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124408 | FOLATE TARGETING OF NUCLEOTIDES | Oct 15, 2009 | Abandoned |
Array
(
[id] => 7568089
[patent_doc_number] => 20110288152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING'
[patent_app_type] => utility
[patent_app_number] => 13/124448
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21800
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288152.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124448 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | Oct 15, 2009 | Abandoned |
Array
(
[id] => 6314748
[patent_doc_number] => 20100112042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/580250
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 48486
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580250 | Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics | Oct 15, 2009 | Abandoned |
Array
(
[id] => 6167881
[patent_doc_number] => 20110196020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3)'
[patent_app_type] => utility
[patent_app_number] => 12/998339
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8902
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998339 | TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3) | Oct 12, 2009 | Abandoned |
Array
(
[id] => 5929950
[patent_doc_number] => 20110039909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHODS AND MATERIALS FOR REDUCING GLI2 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/578304
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11594
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039909.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578304
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578304 | METHODS AND MATERIALS FOR REDUCING GLI2 EXPRESSION | Oct 12, 2009 | Abandoned |
Array
(
[id] => 6497642
[patent_doc_number] => 20100093987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Inhibitor Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 12/576146
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23070
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093987.pdf
[firstpage_image] =>[orig_patent_app_number] => 12576146
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/576146 | Inhibitor Nucleic Acids | Oct 7, 2009 | Abandoned |
Array
(
[id] => 6015763
[patent_doc_number] => 20110223656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'MicroRNAs and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/565693
[patent_app_country] => US
[patent_app_date] => 2009-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15268
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223656.pdf
[firstpage_image] =>[orig_patent_app_number] => 12565693
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/565693 | MicroRNAs and Uses Thereof | Sep 22, 2009 | Abandoned |
Array
(
[id] => 6375819
[patent_doc_number] => 20100076057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'TARGET DNA INTERFERENCE WITH crRNA'
[patent_app_type] => utility
[patent_app_number] => 12/565589
[patent_app_country] => US
[patent_app_date] => 2009-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11491
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12565589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/565589 | TARGET DNA INTERFERENCE WITH crRNA | Sep 22, 2009 | Abandoned |
Array
(
[id] => 6645156
[patent_doc_number] => 20100227908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'DIAGNOSTIC, PROGNOSTIC AND TREATMENT METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/564848
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14534
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564848
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564848 | DIAGNOSTIC, PROGNOSTIC AND TREATMENT METHODS | Sep 21, 2009 | Abandoned |
Array
(
[id] => 6352709
[patent_doc_number] => 20100331389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides'
[patent_app_type] => utility
[patent_app_number] => 12/586281
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29013
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12586281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/586281 | Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides | Sep 16, 2009 | Abandoned |
Array
(
[id] => 6163496
[patent_doc_number] => 20110160288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/061105
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34990
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160288.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061105
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061105 | OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS | Aug 23, 2009 | Abandoned |
Array
(
[id] => 7501963
[patent_doc_number] => 20110263679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/061098
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31791
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263679.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061098
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061098 | C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS | Aug 20, 2009 | Abandoned |
Array
(
[id] => 7663749
[patent_doc_number] => 20110313018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'CANCER RELATED GENE, LGN/GPSM2'
[patent_app_type] => utility
[patent_app_number] => 13/061123
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35479
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313018.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061123 | CANCER RELATED GENE, LGN/GPSM2 | Aug 20, 2009 | Abandoned |
Array
(
[id] => 6372799
[patent_doc_number] => 20100080815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'MN Gene and Protein'
[patent_app_type] => utility
[patent_app_number] => 12/543026
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 30284
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080815.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543026
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543026 | MN Gene and Protein | Aug 17, 2009 | Abandoned |
Array
(
[id] => 6578289
[patent_doc_number] => 20100047336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 12/542635
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11156
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047336.pdf
[firstpage_image] =>[orig_patent_app_number] => 12542635
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/542635 | INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION | Aug 16, 2009 | Abandoned |
Array
(
[id] => 7720931
[patent_doc_number] => 20120010266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/061118
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 46505
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010266.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061118
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061118 | TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER | Aug 13, 2009 | Abandoned |
Array
(
[id] => 6479512
[patent_doc_number] => 20100041736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Isolated MCPIP and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/539907
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13846
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041736.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539907 | Isolated MCPIP and Methods of Use | Aug 11, 2009 | Abandoned |